#METABOLOMICS WORKBENCH stephensondj_20230908_115906 DATATRACK_ID:4299 STUDY_ID:ST002857 ANALYSIS_ID:AN004682
VERSION                          	1
CREATED_ON                       	09-13-2023
#PROJECT
PR:PROJECT_TITLE                 	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells
PR:PROJECT_TITLE                 	in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I
PR:PROJECT_TITLE                 	dose-escalation clinical trial
PR:PROJECT_TYPE                  	MS untargeted analysis
PR:PROJECT_SUMMARY               	SUMMARY This is an open-label, first-in-human, dose-escalation phase I study
PR:PROJECT_SUMMARY               	(NCT03282760, EudraCT2015‐004855‐37) to determine the feasibility, safety,
PR:PROJECT_SUMMARY               	and tolerability of the transplantation of allogeneic human neural
PR:PROJECT_SUMMARY               	stem/progenitor cells (hNSCs) for the treatment of progressive multiple
PR:PROJECT_SUMMARY               	sclerosis. We report the analysis of 1 year of data from the first cohort of 15
PR:PROJECT_SUMMARY               	patients from two trial sites that received increasing numbers of allogeneic
PR:PROJECT_SUMMARY               	hNSCs delivered via intracerebroventricular injection in combination with an
PR:PROJECT_SUMMARY               	immunosuppressive regimen. No treatment-related deaths nor serious adverse
PR:PROJECT_SUMMARY               	events (AEs) were observed over the 12-month follow-up. Participants displayed
PR:PROJECT_SUMMARY               	stability of clinical and laboratory parameters, as well as lesion load and
PR:PROJECT_SUMMARY               	activity at the brain MRIs, compared to study entry. Longitudinal metabolomics
PR:PROJECT_SUMMARY               	and lipidomics analyses of cerebrospinal fluid and serum from these patients
PR:PROJECT_SUMMARY               	identified time and dose-dependent responses, with increased levels of free
PR:PROJECT_SUMMARY               	fatty acids and acylcarnitines in the CSF, especially at the highest dose of
PR:PROJECT_SUMMARY               	injected hNSCs at the one-year follow-up time point. Finally, a significant
PR:PROJECT_SUMMARY               	inverse correlation was found between the highest dose of injected hNSCs and the
PR:PROJECT_SUMMARY               	smaller parenchymal brain volume change (PBVC; Spearman’s rho= -0.7, p= 0.03),
PR:PROJECT_SUMMARY               	clinical covariates that correlated with CSF levels of free fatty acids,
PR:PROJECT_SUMMARY               	acyl-carnitines, oxylipins, conjugated bile acids and purine breakdown and
PR:PROJECT_SUMMARY               	deamination products, such as hypoxanthine. The absence of AEs and the stability
PR:PROJECT_SUMMARY               	of functional and structural outcomes is reassuring in terms of risks and
PR:PROJECT_SUMMARY               	represent a main milestone to rigorously address the challenges for the safe
PR:PROJECT_SUMMARY               	translation of key principles of stem cell biology into effective regenerative
PR:PROJECT_SUMMARY               	medicines.  
PR:INSTITUTE                     	University of Colorado
PR:DEPARTMENT                    	Department of Biochemistry and Molecular Genetics
PR:LABORATORY                    	Angelo D’Alessandro
PR:LAST_NAME                     	Stephenson
PR:FIRST_NAME                    	Daniel
PR:ADDRESS                       	Research 1 South L18-1303 12801 E. 17th Ave., Aurora, Colorado, 80045, USA
PR:EMAIL                         	daniel.stephenson@cuanschutz.edu
PR:PHONE                         	303-724-3339
PR:DOI                           	http://dx.doi.org/10.21228/M8G43R
#STUDY
ST:STUDY_TITLE                   	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells
ST:STUDY_TITLE                   	in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I
ST:STUDY_TITLE                   	dose-escalation clinical trial - Metabolomics Analysis of Human CSF
ST:STUDY_SUMMARY                 	This is an open-label, first-in-human, dose-escalation phase I study
ST:STUDY_SUMMARY                 	(NCT03282760, EudraCT2015‐004855‐37) to determine the feasibility, safety,
ST:STUDY_SUMMARY                 	and tolerability of the transplantation of allogeneic human neural
ST:STUDY_SUMMARY                 	stem/progenitor cells (hNSCs) for the treatment of progressive multiple
ST:STUDY_SUMMARY                 	sclerosis. We report the analysis of 1 year of data from the first cohort of 15
ST:STUDY_SUMMARY                 	patients from two trial sites that received increasing numbers of allogeneic
ST:STUDY_SUMMARY                 	hNSCs delivered via intracerebroventricular injection in combination with an
ST:STUDY_SUMMARY                 	immunosuppressive regimen. No treatment-related deaths nor serious adverse
ST:STUDY_SUMMARY                 	events (AEs) were observed over the 12-month follow-up. Participants displayed
ST:STUDY_SUMMARY                 	stability of clinical and laboratory parameters, as well as lesion load and
ST:STUDY_SUMMARY                 	activity at the brain MRIs, compared to study entry. Longitudinal metabolomics
ST:STUDY_SUMMARY                 	and lipidomics analyses of cerebrospinal fluid and serum from these patients
ST:STUDY_SUMMARY                 	identified time and dose-dependent responses, with increased levels of free
ST:STUDY_SUMMARY                 	fatty acids and acylcarnitines in the CSF, especially at the highest dose of
ST:STUDY_SUMMARY                 	injected hNSCs at the one-year follow-up time point. Finally, a significant
ST:STUDY_SUMMARY                 	inverse correlation was found between the highest dose of injected hNSCs and the
ST:STUDY_SUMMARY                 	smaller parenchymal brain volume change (PBVC; Spearman’s rho= -0.7, p= 0.03),
ST:STUDY_SUMMARY                 	clinical covariates that correlated with CSF levels of free fatty acids,
ST:STUDY_SUMMARY                 	acyl-carnitines, oxylipins, conjugated bile acids and purine breakdown and
ST:STUDY_SUMMARY                 	deamination products, such as hypoxanthine. The absence of AEs and the stability
ST:STUDY_SUMMARY                 	of functional and structural outcomes is reassuring in terms of risks and
ST:STUDY_SUMMARY                 	represent a main milestone to rigorously address the challenges for the safe
ST:STUDY_SUMMARY                 	translation of key principles of stem cell biology into effective regenerative
ST:STUDY_SUMMARY                 	medicines.
ST:INSTITUTE                     	University of Colorado
ST:DEPARTMENT                    	Department of Biochemistry and Molecular Genetics
ST:LABORATORY                    	Angelo D’Alessandro
ST:LAST_NAME                     	Stephenson
ST:FIRST_NAME                    	Daniel
ST:ADDRESS                       	Research 1 South L18-1303 12801 E. 17th Ave., Aurora, Colorado, 80045, USA
ST:EMAIL                         	daniel.stephenson@cuanschutz.edu
ST:PHONE                         	303-724-3339
ST:SUBMIT_DATE                   	2023-09-08
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:GENDER                        	Male and female
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-005	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-005+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005-neg_oxylipinsCSF.mzXML; ID=1
SUBJECT_SAMPLE_FACTORS           	1219	DS1-123-032	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-032+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032-neg_oxylipinsCSF.mzXML; ID=2
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-035	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-035+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035-neg_oxylipinsCSF.mzXML; ID=3
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-046	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-046+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046-neg_oxylipinsCSF.mzXML; ID=4
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-057	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-057+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057-neg_oxylipinsCSF.mzXML; ID=5
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-070	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-070+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070-neg_oxylipinsCSF.mzXML; ID=6
SUBJECT_SAMPLE_FACTORS           	1243	DS1-123-072	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-072+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072-neg_oxylipinsCSF.mzXML; ID=7
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-094	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-094+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094-neg_oxylipinsCSF.mzXML; ID=8
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-100	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-100+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100-neg_oxylipinsCSF.mzXML; ID=9
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-103	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-103+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103-neg_oxylipinsCSF.mzXML; ID=10
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-125	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-125+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125-neg_oxylipinsCSF.mzXML; ID=11
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-134	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-134+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134-neg_oxylipinsCSF.mzXML; ID=12
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-139	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-139+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139-neg_oxylipinsCSF.mzXML; ID=13
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-146	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-146+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146-neg_oxylipinsCSF.mzXML; ID=14
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-027	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-027+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027-neg_oxylipinsCSF.mzXML; ID=15
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-031	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-031+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031-neg_oxylipinsCSF.mzXML; ID=16
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-058	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-058+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058-neg_oxylipinsCSF.mzXML; ID=17
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-063	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-063+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063-neg_oxylipinsCSF.mzXML; ID=18
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-073	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-073+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073-neg_oxylipinsCSF.mzXML; ID=19
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-093	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-093+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093-neg_oxylipinsCSF.mzXML; ID=20
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-111	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-111+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111-neg_oxylipinsCSF.mzXML; ID=21
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-124	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-124+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124-neg_oxylipinsCSF.mzXML; ID=22
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-136	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-136+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136-neg_oxylipinsCSF.mzXML; ID=23
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-148	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-148+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148-neg_oxylipinsCSF.mzXML; ID=24
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-011	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-011+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011-neg_oxylipinsCSF.mzXML; ID=25
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-018	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-018+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018-neg_oxylipinsCSF.mzXML; ID=26
SUBJECT_SAMPLE_FACTORS           	1228	DS1-123-037	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-037+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037-neg_oxylipinsCSF.mzXML; ID=27
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-043	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-043+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043-neg_oxylipinsCSF.mzXML; ID=28
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-080	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-080+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080-neg_oxylipinsCSF.mzXML; ID=29
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-083	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-083+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083-neg_oxylipinsCSF.mzXML; ID=30
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-105	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-105+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105-neg_oxylipinsCSF.mzXML; ID=31
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-127	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-127+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127-neg_oxylipinsCSF.mzXML; ID=32
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-007	TimeGroup:REND	RAW_FILE_NAME=DS1-123-007+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007-neg_oxylipinsCSF.mzXML; ID=33
SUBJECT_SAMPLE_FACTORS           	1228	DS1-123-021	TimeGroup:REND	RAW_FILE_NAME=DS1-123-021+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021-neg_oxylipinsCSF.mzXML; ID=34
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-028	TimeGroup:REND	RAW_FILE_NAME=DS1-123-028+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028-neg_oxylipinsCSF.mzXML; ID=35
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-042	TimeGroup:REND	RAW_FILE_NAME=DS1-123-042+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042-neg_oxylipinsCSF.mzXML; ID=36
SUBJECT_SAMPLE_FACTORS           	1316	DS1-123-050	TimeGroup:REND	RAW_FILE_NAME=DS1-123-050+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050-neg_oxylipinsCSF.mzXML; ID=37
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-071	TimeGroup:REND	RAW_FILE_NAME=DS1-123-071+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071-neg_oxylipinsCSF.mzXML; ID=38
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-087	TimeGroup:REND	RAW_FILE_NAME=DS1-123-087+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087-neg_oxylipinsCSF.mzXML; ID=39
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-102	TimeGroup:REND	RAW_FILE_NAME=DS1-123-102+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102-neg_oxylipinsCSF.mzXML; ID=40
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-106	TimeGroup:REND	RAW_FILE_NAME=DS1-123-106+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106-neg_oxylipinsCSF.mzXML; ID=41
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-116	TimeGroup:REND	RAW_FILE_NAME=DS1-123-116+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116-neg_oxylipinsCSF.mzXML; ID=42
SUBJECT_SAMPLE_FACTORS           	1243	DS1-123-117	TimeGroup:REND	RAW_FILE_NAME=DS1-123-117+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117-neg_oxylipinsCSF.mzXML; ID=43
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-123	TimeGroup:REND	RAW_FILE_NAME=DS1-123-123+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123-neg_oxylipinsCSF.mzXML; ID=44
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-131	TimeGroup:REND	RAW_FILE_NAME=DS1-123-131+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131-neg_oxylipinsCSF.mzXML; ID=45
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-133	TimeGroup:REND	RAW_FILE_NAME=DS1-123-133+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133-neg_oxylipinsCSF.mzXML; ID=46
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-145	TimeGroup:REND	RAW_FILE_NAME=DS1-123-145+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145-neg_oxylipinsCSF.mzXML; ID=47
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-001	TimeGroup:START	RAW_FILE_NAME=DS1-123-001+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001-neg_oxylipinsCSF.mzXML; ID=48
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-003	TimeGroup:START	RAW_FILE_NAME=DS1-123-003+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003-neg_oxylipinsCSF.mzXML; ID=49
SUBJECT_SAMPLE_FACTORS           	1219	DS1-123-014	TimeGroup:START	RAW_FILE_NAME=DS1-123-014+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014-neg_oxylipinsCSF.mzXML; ID=50
SUBJECT_SAMPLE_FACTORS           	1228	DS1-123-015	TimeGroup:START	RAW_FILE_NAME=DS1-123-015+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015-neg_oxylipinsCSF.mzXML; ID=51
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-025	TimeGroup:START	RAW_FILE_NAME=DS1-123-025+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025-neg_oxylipinsCSF.mzXML; ID=52
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-039	TimeGroup:START	RAW_FILE_NAME=DS1-123-039+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039-neg_oxylipinsCSF.mzXML; ID=53
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-051	TimeGroup:START	RAW_FILE_NAME=DS1-123-051+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051-neg_oxylipinsCSF.mzXML; ID=54
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-076	TimeGroup:START	RAW_FILE_NAME=DS1-123-076+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076-neg_oxylipinsCSF.mzXML; ID=55
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-081	TimeGroup:START	RAW_FILE_NAME=DS1-123-081+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081-neg_oxylipinsCSF.mzXML; ID=56
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-085	TimeGroup:START	RAW_FILE_NAME=DS1-123-085+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085-neg_oxylipinsCSF.mzXML; ID=57
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-099	TimeGroup:START	RAW_FILE_NAME=DS1-123-099+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099-neg_oxylipinsCSF.mzXML; ID=58
SUBJECT_SAMPLE_FACTORS           	1243	DS1-123-109	TimeGroup:START	RAW_FILE_NAME=DS1-123-109+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109-neg_oxylipinsCSF.mzXML; ID=59
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-114	TimeGroup:START	RAW_FILE_NAME=DS1-123-114+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114-neg_oxylipinsCSF.mzXML; ID=60
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-130	TimeGroup:START	RAW_FILE_NAME=DS1-123-130+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130-neg_oxylipinsCSF.mzXML; ID=61
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-142	TimeGroup:START	RAW_FILE_NAME=DS1-123-142+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142-neg_oxylipinsCSF.mzXML; ID=62
#COLLECTION
CO:COLLECTION_SUMMARY            	lumbar puncture for serum and CSF collection (stored at -80°C)
CO:SAMPLE_TYPE                   	CSF
#TREATMENT
TR:TREATMENT_SUMMARY             	A total of 180 candidates volunteered between September 26, 2017, and January
TR:TREATMENT_SUMMARY             	13, 2020. The study was conducted in three centers. Two Italian centers, the
TR:TREATMENT_SUMMARY             	‘IRCCS Casa Sollievo della Sofferenza’ Research Hospital (Site 1) and the
TR:TREATMENT_SUMMARY             	‘Santa Maria di Terni’ Hospital (Site 2) recruited patients and performed
TR:TREATMENT_SUMMARY             	the MRI examinations. The Multiple Sclerosis Centre of the Neurocentre of
TR:TREATMENT_SUMMARY             	Southern Switzerland (Site 3) performed the magnetic resonance imaging (MRI)
TR:TREATMENT_SUMMARY             	analysis. The ICVI of the ACT was performed at Site 2. Screening was done one
TR:TREATMENT_SUMMARY             	month prior to enrolment in the study. The run-in period started after the
TR:TREATMENT_SUMMARY             	screening examination (Run-in-START) and lasted three months (Run-in-END). After
TR:TREATMENT_SUMMARY             	screening in the two recruiting centers (as above), n= 15 subjects with active
TR:TREATMENT_SUMMARY             	and non-active SPMS suffering from progressive disability were found to be
TR:TREATMENT_SUMMARY             	eligible, consented, and were assigned a unique identification number.
TR:TREATMENT_SUMMARY             	Participants, nine females and six males, had a mean age of 50 years (range:
TR:TREATMENT_SUMMARY             	38–57), and were recruited in similar proportions by the two study sites. The
TR:TREATMENT_SUMMARY             	mean EDSS was 7.6 (range 7–8), mean disease duration was 23 years (range
TR:TREATMENT_SUMMARY             	14–30), and mean time from diagnosis to secondary progression was 10 years
TR:TREATMENT_SUMMARY             	(range: 1–20). The hNSC-SPMS study was advertised using the website of the
TR:TREATMENT_SUMMARY             	hospitals and social media (eg Facebook and Twitter). The first patient
TR:TREATMENT_SUMMARY             	selection was performed based on the documentation provided. Selected patients
TR:TREATMENT_SUMMARY             	were then summoned in Site 1 and Site 2 (as above) for a first pre-screening
TR:TREATMENT_SUMMARY             	meeting with the clinicians. Patients who agreed to participate were then
TR:TREATMENT_SUMMARY             	subjected to the screening visit for the clinical trial. Following the surgical
TR:TREATMENT_SUMMARY             	procedure, follow-up visits were performed monthly up to 12 months. Before
TR:TREATMENT_SUMMARY             	transplantation, all patients underwent the following examinations (at both
TR:TREATMENT_SUMMARY             	Run-in-START and Run-in-END): physical and neurological exams; vital signs;
TR:TREATMENT_SUMMARY             	pregnancy tests (in fertile women); haematological and urine tests; lumbar
TR:TREATMENT_SUMMARY             	puncture for serum and CSF collection (stored at -80°C);
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Extraction of metabolites and lipids from serum and cerebrospinal fluid (CSF)
SP:SAMPLEPREP_SUMMARY            	was as follows: 40 µL CSF or serum was aliquoted into 2mL deep well plates
SP:SAMPLEPREP_SUMMARY            	followed by an addition of 360 µL cold MeOH:MeCN:H2O (5:3:2, v:v:v). Plates
SP:SAMPLEPREP_SUMMARY            	were then placed on a shaker at 4°C and plate shaker was set to 400 RPM for 30
SP:SAMPLEPREP_SUMMARY            	minutes. Insoluble material was pelleted by centrifugation (4000 RPM, 10 min)
SP:SAMPLEPREP_SUMMARY            	and supernatants were isolated for analysis by UHPLC-MS. All 96-well plate
SP:SAMPLEPREP_SUMMARY            	pipetting was done using Integra MINI 96 (Integra Biosciences).
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Lipidomics Positive
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Phenomenex Kinetex C18 (30 x 2.1mm, 1.7um)
CH:COLUMN_TEMPERATURE            	50
CH:FLOW_GRADIENT                 	0 min - 0.3ml/min - 30%B, 3 min - 0.3ml/min - 100%B, 4.2min - 0.3ml/min -100%B,
CH:FLOW_GRADIENT                 	4.3min - 0.4ml/min - 30%B, 4.9min - 0/4ml/min - 30%B, 5 min - 0.3ml/min 30%B
CH:FLOW_RATE                     	0.3-.4ml/min
CH:SOLVENT_A                     	75:25 H2O:ACN 5mM NH4OAc
CH:SOLVENT_B                     	90:10 iPrOH:ACN 5mM NH4OAc
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:MS_COMMENTS                   	Software for Feature Assignments - Lipidsearch
MS:ION_MODE                      	POSITIVE
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS         	Peak area
MS_METABOLITE_DATA_START
Samples	DS1-123-005	DS1-123-032	DS1-123-035	DS1-123-046	DS1-123-057	DS1-123-070	DS1-123-072	DS1-123-094	DS1-123-100	DS1-123-103	DS1-123-125	DS1-123-134	DS1-123-139	DS1-123-146	DS1-123-027	DS1-123-031	DS1-123-058	DS1-123-063	DS1-123-073	DS1-123-093	DS1-123-111	DS1-123-124	DS1-123-136	DS1-123-148	DS1-123-011	DS1-123-018	DS1-123-037	DS1-123-043	DS1-123-080	DS1-123-083	DS1-123-105	DS1-123-127	DS1-123-007	DS1-123-021	DS1-123-028	DS1-123-042	DS1-123-050	DS1-123-071	DS1-123-087	DS1-123-102	DS1-123-106	DS1-123-116	DS1-123-117	DS1-123-123	DS1-123-131	DS1-123-133	DS1-123-145	DS1-123-001	DS1-123-003	DS1-123-014	DS1-123-015	DS1-123-025	DS1-123-039	DS1-123-051	DS1-123-076	DS1-123-081	DS1-123-085	DS1-123-099	DS1-123-109	DS1-123-114	DS1-123-130	DS1-123-142
Factors	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	
AcCa(2:0)	476962.3400	377560.4100	469627.3800	545531.4400	284274.3800	402977.1600	261764.5000	951153.6900	330250.1600	726115.1900	315869.1200	358025.5000	532385.5000	273258.0900	669987.1900	545218.6900	336372.6600	328654.6600	538821.6900	649485.7500	423914.5900	294885.8800	382493.6600	318933.9100	368259.6600	289975.4700	390669.5900	301120.6200	474991.3800	369907.3400	445472.7500	305440.4100	440727.5900	433578.5000	356885.6200	527964.8100	327289.9700	332917.3400	246468.5500	295378.4100	371210.7500	276425.0000	336288.7200	297347.0000	299487.0900	350974.4700	1126576.8800	494432.7500	269952.1200	473516.3800	549914.5600	828354.9400	367997.2800	368537.8400	259628.6700	342087.3100	361164.0300	462803.0000	669708.1900	283174.1900	502154.8400	356047.2800
Cer(d16:0_16:0)	33321.9600	29366.9800	53916.3100	65053.0000	48144.8600	48800.8000	72223.4000	45313.0800	29154.1600	60570.6100	35458.3700	41442.8200	54105.2800	30338.8300	51116.2800	45750.5800	36454.1900	61566.9200	50718.3400	51038.9100	48041.4500	64265.7100	45921.6600	27801.3600	29908.0800	16851.4600	52345.2500	29444.1400	54913.7000	43838.5300	28359.1900	73142.4600	44227.1100	40422.7900	33147.4100	30836.4600	53069.1100	27238.1300	50001.8900	23617.6400	48413.0900	45012.4200	36926.1100	51291.4000	32644.7900	24008.6200	78685.8400	46776.5000	53891.9700	41391.6800	47950.6800	59972.6200	52579.8900	44845.2600	30988.2600	42553.2500	47268.2800	17183.5000	51535.7100	23992.2800	27168.9700	62249.7300
Cer(d16:0_18:0)	3211209.7500	2869870.0000	3269625.0000	3120231.2500	1769674.8800	2484289.7500	2924540.0000	2557859.2500	2028134.6200	2841858.7500	2560676.2500	2750199.2500	2068278.0000	2706310.0000	3184992.2500	2932846.7500	2357224.2500	2653978.2500	2779586.2500	3257357.7500	3221606.0000	2182741.0000	2436111.5000	1701461.8800	2597394.2500	1522029.1200	1952200.5000	2050405.3800	2940183.2500	2518372.7500	2283455.0000	2293326.2500	3758510.0000	2514469.5000	2811459.2500	3159624.2500	2395309.2500	2527469.2500	2082776.6200	2070195.8800	3315584.7500	1753700.0000	2633753.0000	1989773.0000	2155865.2500	2335650.0000	2467703.2500	3888393.0000	3325706.7500	2286734.7500	4167777.2500	1866349.0000	3195820.0000	2266867.7500	2004234.6200	1962689.0000	2010060.3800	3317110.2500	3061630.7500	2605195.5000	3077048.0000	3812979.7500
DAP(O-16:0_O-4:0)	90422.5600	126711.5900	86137.1500	190825.0500	83028.7900	173250.8800	100622.9800	130467.0200	102394.6600	160437.1700	117149.0000	123268.8800	128796.2300	84998.1200	152473.1700	208955.6400	64619.8300	143031.8000	173484.8800	97889.9700	126459.3400	146506.9500	134524.8300	147797.8300	122095.4600	224934.9400	205182.7300	133499.9400	199165.6700	195652.0800	101836.3100	135850.8300	99097.3000	173865.4700	96694.2500	97837.4500	175158.8800	155865.8900	62130.4300	142126.2000	227289.4200	112517.8700	102136.4600	211030.8800	109381.3800	127041.2200	176762.9400	149497.5800	137030.9800	102050.6000	93182.6500	164643.8900	113767.4100	125876.7800	128797.9700	102933.4300	134289.0600	137140.1100	149899.0300	140212.0800	113004.3500	131145.9200
DG(7:0_11:0)			4581.4300		15104.5300		1056.8600					3459.1000		4068.0900	1170.0100	14698.6600	15462.7400	1108.9800								4156.5300		2711.4900			11873.6400																											4197.3800	14000.6800			
DG(O-15:1_19:1)	12433016.0000	9679021.0000	9940137.0000	13228643.0000	11278779.0000	15221868.0000	12444684.0000	11276336.0000	11730389.0000	11564299.0000	12083344.0000	12161017.0000	11489175.0000	13264757.0000	11622453.0000	8594802.0000	8040984.0000	6802392.0000	12574237.0000	13404253.0000	10997869.0000	9280779.0000	10996642.0000	8595315.0000	13386141.0000	8991159.0000	8917769.0000	8882311.0000	12717888.0000	11556073.0000	14144396.0000	9482697.0000	18309154.0000	15616379.0000	11604241.0000	12705712.0000	13320459.0000	14359492.0000	7887177.5000	11552960.0000	12759272.0000	9179936.0000	11738504.0000	9700409.0000	11796296.0000	10891072.0000	12733488.0000	11099998.0000	11503245.0000	13882308.0000	11592043.0000	10644664.0000	11940416.0000	10920835.0000	11637948.0000	9467973.0000	6071221.5000	11369913.0000	10897009.0000	13326340.0000	15086488.0000	14023453.0000
DG(O-16:0)	234930.0600	220039.3800	195497.5600	274797.9700	233403.9200	250781.6200	163395.2000	169334.3900	130060.7700	256857.2000	147610.3000	221063.3100	245884.5800	182523.7000	239126.2000	162928.6700	268651.7200	235471.8900	247355.6900	228709.0800	198451.3000	167815.3300	175836.8300	193558.3000	204489.6100	210388.7500	245068.1700	194887.6100	231778.4500	169959.5200	157656.2700	166776.4200	240315.7500	206122.3000	207573.0800	185308.7000	167597.4200	176555.2700	258863.1700	178638.6100	256854.3300	155007.6100	253959.8300	214764.0800	188625.4500	204629.1100	319416.0900	205516.4800	258633.2700	127998.1200	242342.2500	147195.4200	172966.0200	295487.6900	252832.8300	131166.2300	177960.3000	218129.4400	203580.7300	196602.7700	130453.2400	242830.1200
DG(O-18:0)	466684.1200	323309.4100	455652.4700	628992.3100	373761.0900	466634.2200	644789.6200	353808.7500	260748.0500	777669.6900	356350.0300	273523.9700	248778.9400	532405.5000	438877.3400	422785.5000	463158.1600	441088.5300	678887.6900	431121.3400	243596.0800	742707.5000	463528.7200	458437.1600	263540.4700	509702.2500	476953.7800	627144.0600	361525.5000	556641.1200	348954.1900	599567.2500	533033.4400	302809.8100	371490.2500	352420.3400	288924.8800	382675.0900	469955.5300	655573.7500	417517.9100	470266.7800	439954.8800	417268.2500	358900.3400	643875.8800	503951.0900	294334.9700	646118.3800	233676.9500	607854.5000	534331.5600	405937.9700	406381.0000	484556.5000	302217.5000	353803.7800	264860.2200	317499.4700	523420.7200	257660.0200	602479.3100
LPC(16:0)	412529.1600	116693.0400	270303.6200	308694.2800	285900.0900	359719.2500	193914.8300	351166.2500	532236.0000	249777.9500	208483.1700	227728.8300	418340.8400	275139.7800	187242.5800	415769.3400	403775.4700	154938.7300	263864.6200	408063.0000	277836.6200	268297.1600	304175.3400	118804.3100	147198.5200	191673.9500	157968.9500	183973.6700	170732.6700	326726.5900	410026.2800	301302.7800	147455.0200	199663.4800	300250.7200	357138.5000	178710.3800	199798.6900	260037.3300	218317.0800	131205.0500	305870.3400	417193.4100	182229.7700	162850.2800	249419.6900	247025.5500	68292.2400	244417.1700	690282.5600	193034.7000	919419.5000	443799.2200	222585.8000	162875.1400	422302.8400	420310.5900	261120.9500	367487.5900	102156.4700	748854.3100	208117.4800
LPC(18:0)	4337479.5000	3193539.2500	2644957.0000	4668348.0000	3131053.0000	3210828.7500	3410632.7500	4868991.5000	2584229.7500	5526102.0000	2881285.2500	3661764.0000	5543769.0000	3728896.0000	2684650.7500	3555385.7500	3553143.7500	2881123.7500	4222844.5000	3186427.7500	1644639.5000	3416841.7500	2615145.7500	3528071.7500	1970014.3800	2184860.7500	3739121.7500	2821760.7500	5423597.0000	3861156.7500	4538710.5000	3586592.0000	2577375.7500	4353658.0000	3796890.0000	3731596.7500	3781145.2500	4018972.0000	2787845.0000	2409298.7500	4141013.7500	3221326.7500	1040513.8100	3506557.2500	895335.5000	3048128.2500	6728831.5000	2318015.7500	3154697.2500	3411799.0000	5955920.5000	5056768.0000	3628758.7500	1676933.6200	2130643.0000	4131777.0000	3307126.7500	2882109.2500	3298137.2500	2905382.2500	2443777.2500	5073190.0000
LPC(18:1)	8873159.0000	11509391.0000	7193798.5000	12928895.0000	14392980.0000	6189500.5000	9068419.0000	10315749.0000	5178681.5000	14972101.0000	5009055.5000	9881228.0000	12672769.0000	6912016.0000	9350381.0000	10505861.0000	11562208.0000	13076523.0000	14581717.0000	11330080.0000	7346059.5000	14468149.0000	7357810.0000	8133592.5000	6073282.5000	6130862.5000	7629237.5000	8825498.0000	13334049.0000	9644084.0000	9922422.0000	11815857.0000	7892693.5000	10765417.0000	9494843.0000	8354114.0000	9713553.0000	5660189.5000	8789333.0000	4895213.5000	11867184.0000	6673646.0000	6217563.5000	9226149.0000	4336642.0000	6327928.0000	23172288.0000	6574229.5000	6923565.5000	5207008.5000	10234969.0000	19338222.0000	9230359.0000	7271248.5000	5726969.5000	9238490.0000	8490852.0000	12788248.0000	12084139.0000	8104325.5000	9797621.0000	8749714.0000
LPC(18:2)	10059675.0000	12919044.0000	6571464.0000	12631112.0000	7156876.5000	7335448.0000	6859469.5000	12135832.0000	8030816.5000	13963701.0000	5988448.0000	9996536.0000	11041105.0000	7787274.5000	8269840.5000	9733593.0000	11665000.0000	8373012.0000	13104427.0000	6167288.0000	5971044.5000	9774177.0000	5469945.5000	12968136.0000	4427242.0000	5877639.5000	13420720.0000	6607416.5000	14451419.0000	9772998.0000	8244990.0000	11125554.0000	6871698.0000	11712041.0000	7566396.0000	7037824.0000	9404445.0000	7496308.0000	10623915.0000	5664708.0000	17972906.0000	8407579.0000	3588129.0000	11994679.0000	2509925.0000	5266855.5000	20118180.0000	4554114.5000	11446317.0000	10553120.0000	12597279.0000	14677533.0000	9185339.0000	7763218.5000	5616490.0000	9526807.0000	10311298.0000	8951482.0000	8422580.0000	8387308.0000	5868017.5000	10293791.0000
LPC(20:3)	589960.9400	910275.1900	590394.7500	896190.6900	309957.1200	572859.6900	474201.5000	576799.0600	424650.2200	1071540.6200	435903.2800	524096.5900	777535.1900	597078.7500	477301.1600	424435.2200	367922.0000	568699.3800	580583.7500	670899.0600	583848.8800	420695.7500	423264.2500	472532.3800	465041.4100	268203.7800	517106.9100	444852.0300	597448.1900	459173.5300	607130.5000	511739.3800	650967.3100	603050.0600	891362.6900	839913.5000	699793.7500	388951.6200	590092.8100	317607.4700	738430.1900	648066.9400	364982.6600	391941.3400	503495.7500	368524.9700	838030.0000	517852.9100	502535.9100	315921.6200	476723.4100	350610.7500	669859.6900	575283.8100	413671.1600	390035.0900	469272.2500	312781.4700	487242.5000	617308.5600	370914.5900	982379.8100
MG(16:0)	51025.4200	24842.3600	42696.2500	56169.6700	21433.0100	102804.9700	41029.8400	43035.8100	114366.0200	22245.7400	51923.2100	40811.2100	67880.5400	25683.9200		68855.9700	48894.6800	26386.6400	69740.8800	40120.3900	54966.2500	41393.9300	40626.8400	34481.5100	30820.1500	58292.1900		42312.5200	25984.3100	49705.6600	40915.3000	51614.8100	34312.8500	30202.7500	36926.5400	30598.0200	84223.5900	50231.0000	22823.4500	42534.8900	21655.1700	37325.5500	48227.8900	28215.0500	16184.4600	44324.9800	28119.5700	44670.2400	20659.0700	45887.9500	37160.4600	44967.6800	115614.5600	25027.8500	30900.3500	98860.0900	62767.6400	28365.9000	81454.5900	32114.0300	33685.9500	40202.0000
MG(18:2)	2403.2000		7761.4200	2429.2000	6508.0300	18195.7100	7893.7500		9507.6300	11730.0600	4463.2800	1543.2000	2317.5400	4348.2000	7451.7400	3239.1500		1403.1100		13656.9200	2340.4100	4881.1100	5689.7700			8375.1600	4663.3600	18472.0800	7718.6300	2311.6600	7369.8300	5443.6000	6359.4800	5299.3500	5177.8200	9567.8900	8553.9400	17219.3100	2435.2800	5503.7500	58003.0700	3902.9400	2091.7000		944.8300	10407.1900	19391.9800	1841.2900	13192.5800	8743.0500	8150.0500	2083.1200	13858.6800		5158.4800	2425.4100	8991.0500	17486.1700	12026.6300	5242.9100	8087.3600	1152.0300
PC(32:0)	70413.5500			58968.2700	11770.3700	48887.7900	23535.1300	23984.8900	89201.1000	35413.7000		42176.2300	75504.5900	16610.1900	30895.4400	65029.7900	75629.7000		65318.5300	49951.9400		24282.3000		21909.3100			35943.2900			15466.2100	56577.2700	47383.7000	22905.2900	44626.0600	54317.6800	21799.6700	19986.2100			19829.6300	16132.7500			20286.5400			54717.9300			115873.2000	43582.7000	94325.8800	90734.1300			87345.8700	30858.7100		48160.3600		53093.6200	41625.6600
PC(32:1)	35518.3800	24455.1600	41890.0200	68767.2700	40817.9600	51683.7500	32452.1600	77308.2300	30315.5900	82788.7900	19108.5700	42449.1200	75354.9100	26885.8300	31077.6700	58840.6900	51574.7500	50811.0000	70127.0500	89639.3400	47596.9700	56509.2200	19525.4700	36074.4100	24984.8300	15147.7800	29412.9000	27613.4800	57257.9700	34236.3800	66767.6900	47622.9500	38694.6000	36101.6900	45680.4600	48522.7700	35888.8100	29713.3900	24531.8400	29842.1200	41542.9300	26718.3400	35145.3000	39316.0800	26573.0200	38063.5100	106670.1900	29751.0900	35358.1900	20429.8200	68218.9300	49158.6100	41790.7300	24231.0800	13644.6700	54555.9700	26053.4400	27020.4700	58834.2800	27182.0700	46816.9200	39417.2100
PC(34:2)	33381.3000	13255.8900	14466.1300	75556.6300	78592.9100	34727.4800	17903.7700	55416.6100	65457.0200	37563.9500	15488.7400	23395.2700	119037.5300			85070.5600	67049.7600	54557.9600	138385.9200	83591.6000		72292.7600	16088.6700	15910.3600					38002.5300	52883.3600	35538.7400	47926.4400	14137.9500		60079.1100	24229.8700	18080.8400		38563.1400		40543.3300	70988.9900		25500.3000	18017.2400		80844.0200			62571.7500	73487.5100	205597.5500	74158.3300	30645.5800		149489.0200	59853.9000	20114.3400	56566.3000		26731.5400	15618.1900
PC(36:2)	19854.6300	31627.9600	21801.5400	14174.6500	18339.9000	36724.0400	32964.1200	17149.1000		21867.3300	27540.5800	19218.8500	14375.3800	18917.8600	47996.7100			9984.7300	15993.6500	19123.8500	19119.7700	4769.9500	18594.4300	24706.3900	27587.5300	7143.2400	23040.9500	26797.0200	36050.4500	15044.8600	12573.3300	62175.0800	20320.3000	16997.1900	17326.3100	15110.3100	11725.9100	16956.0400	18734.9400	33509.9600	33488.7000		21745.0700	15203.4800	29880.1500	31238.9000	29495.0600	16940.0000	28225.1500	5798.5600	16889.4500	15727.0000	1663.8500	37330.4900	24558.7200	13277.6200	13967.5500	18200.8000	20216.6200	38665.2200	8422.9600	22550.9400
PC(36:3)	47925.6200	125501.1200	100325.8800	153345.8900	145340.1700	55832.6100	125913.8400	65117.6600	68308.5900	99351.9800	91657.0400	132435.2000	59035.5400	89862.1600	119854.3400	79495.7300	74524.8000	71549.7400	77069.2300	110467.2100	105593.6900	109068.5300	67540.4700	116560.9800	96296.4000	84874.6100	119020.4100	102284.7100	127069.4100	147938.7300	104904.0900	114161.5900	141383.6700	107286.7900	108093.1200	109204.7600	133672.5600	100722.5300	87386.8800	68879.8000	137972.2800	76952.3200	96274.4300	113121.8800	140872.0200	136566.5600	100289.6600	121126.0300	121619.6600		88831.9100	65319.0600	87309.6200	152187.0200	167643.2000	68615.0200	67600.8300	82011.5500	55876.1400	78158.0500	38752.3800	93634.9600
PC(36:4)		6766.5500		7668.4500	7603.1200	10995.9800	9729.7500	6827.8200	5884.1700		6167.5300		10868.7400	15208.3200	5449.0400	29782.5500	11951.5400		9566.5300	9209.1000	7404.8400	9602.5400	20688.0200	6509.9600	5146.1600	8505.1300		13979.5800	21016.4300	6174.1700	8986.2600	11681.5200	9341.7000	13483.8000	10577.3800	9648.8300	17122.5900	3895.6100	7638.8900	9216.2900	1002.3500		13592.4500		9081.9500		10478.9200	4415.8800						17819.6500	6499.1400	9133.6700		7921.1700	12377.3200			16365.9100
PC(38:4)	97863.7000	66060.1200	134708.7000	112424.3700	92444.4700	48429.1700	81155.8400	104724.7700	72922.1200	100525.0100	70365.9500	91381.5500	108838.4100	95889.2600	53718.0500	75414.3400	59623.1700	78077.1000	101132.2600	83696.0500	67041.2300	118677.4300	63773.4300	86201.4500	87963.0700	87592.1200	76560.1200	63753.0700	131189.6400	76059.1300	102867.6300	129016.5100	84241.6600	99908.3500	48222.1900	88844.4300	126244.2900	68886.7700	90468.4600	83549.9900	101172.0900	82474.6000	112058.9100	59730.6100	67388.0400	86928.4100	120287.3400	78744.4100	101756.3800	71378.8500	91389.0100	59693.1400	70929.7900	62407.1100	74730.8400	96410.7100	66540.6600	37920.0700	51199.5000	91700.9300	80460.7400	112245.8400
PC(38:6)	34410.2000	15320.6800	37902.8500	28266.7000	45128.9600	30136.2700	21043.0300	35532.7100	28102.6900	25290.2600	14973.1600	45061.0800	11870.8100	30036.5800	43331.8300	116457.2800	96517.3400	12478.0400	42090.4800	156282.4400	76032.3300	24219.5400	31582.1400	50998.4900	42984.2100	30039.4500	13614.7500	32163.2300	54674.2000	30518.4300	24494.6400	13705.9000	24055.1100	36590.5000	35972.8200	30682.1900	34212.6700	58276.2500	12846.2300	8822.1000	158404.4500	33373.8700	24527.3800	14460.8600	21017.6000	29723.7700	60751.4500	22192.3400	32723.9000	30377.2100	41397.2600	7503.9600	228937.2000	35404.1300	67924.7000	18003.9400	25678.4700	609580.6900	50490.6400	15634.4800	39169.5700	36410.9300
PC(P-18:0)	21517.9200	27178.9100	21876.3200	26305.5600	30682.9400	39704.4400	22025.5600	61352.2100	35576.5200	33392.7900	26606.5500	62218.9000		42996.9900	76921.1300	21474.7300	26255.4600	29976.0800	81174.3400	62685.4900	98286.5400	23566.6300	65640.3100	49170.4800	33677.0300	76381.8700	39663.4600		18372.8000	41718.7500	50100.9500	57603.9100	73580.3400	117553.4600	27608.4700	37072.5500	29830.4000	37305.2900	52045.6000	101625.1600	56152.8900	30993.0400	43930.8500	18432.6400	22869.8200	46715.1100	41096.8600	68958.9600	20956.0000	26780.7800	62615.0000	17109.7200	19760.5600	34678.8400	20036.2200	80155.2000	26980.0100	20860.1700	52378.5000	37934.2000	15701.1400	45014.1700
SM(d36:1)	672389.0000	720153.5000	584221.9400	674562.9400	720987.5600	820069.5000	742005.2500	644948.5600	626308.6200	694279.4400	873898.5000	891116.9400	492659.7500	728381.8100	810374.8100	581808.9400	406118.5900	656838.5600	777945.5000	549259.3100	763281.5600	606763.1900	808637.6900	790400.3100	828551.0000	686514.5000	586643.5000	724182.9400	761506.5600	583755.6900	570083.0600	668567.8100	780923.6900	944851.6900	721455.5600	840663.5600	697739.5600	875845.8100	506140.7200	757790.5000	633277.4400	423130.4100	655391.2500	635301.5600	767380.5000	807426.5000	633189.7500	699998.6900	743982.8100	586399.5600	627032.2500	336960.3800	481875.4700	610879.0000	879405.2500	488055.5000	462663.5900	680085.8100	709068.3100	842459.9400	538114.0000	831921.6900
TG(14:0_16:0_16:0)	47303.4600	21907.6500	16655.8000	60510.4000	76942.0300	37478.1900	40212.3300	35134.6600	52723.1800	51173.5300	43357.9900	71350.9900	82226.9100	54469.2600	19876.1900	27940.5300	27291.0300	48168.1200	64811.4100	35079.2700	34278.7600	35144.4200	34795.7000	70488.2500	46293.7100	41582.1600	54008.3100	93230.1200	112587.4100	50096.7800	72182.8200	79279.1800	66556.3400	61485.3200	30627.7300	67020.9700	57254.0900	50251.4700	61510.6100	32396.9400	63640.4500	41883.0000	31171.9900	56464.9600	38396.0000	44035.7500	33004.2500	31854.0200	49405.9500	55052.4600	79233.1800	24628.3600	45228.4300	72368.9400	44625.9800	87389.2500	50926.3600	17314.5200	32316.8500	58245.4100	41140.4400	92463.7100
TG(15:0_16:0_16:0)	580133.3100	249119.1400	687123.0600	497271.7800	912001.0000	558800.5600	915224.5600	750430.1900	452181.6200	433060.6600	511820.7200	599792.0600	379527.9700	756445.8100	336382.0000	367674.2500	789933.6900	489557.0300	689074.3100	577262.2500	227802.5500	592081.5600	398525.3400	628859.6900	277291.0600	456185.0000	893114.3100	900694.5000	520592.9100	929423.8100	825433.3100	899340.6900	607976.9400	497486.6600	289229.0900	513183.1200	658497.9400	617512.5600	576052.0000	646584.1900	317623.5900	658806.6900	605551.8100	906674.0600	453370.0000	701615.5600	428692.2500	333308.3400	519712.8800	365735.5900	402187.1600	257283.3300	864854.3100	462991.8400	572031.6200	626508.9400	811577.0000	822693.3100	340321.7500	679310.3100	353141.2500	348697.2200
TG(16:0_16:0_16:0)	345009.2200	130785.3400	406470.5900	493434.0900	418408.0900	294114.1600	522585.5000	298314.5300	314721.6200	425017.5000	237071.5800	315336.9400	222769.2300	333705.0300	286505.5300	270426.6600	222337.9400	218212.5600	450119.0000	428832.5900	196931.5800	295420.2800	379865.6200	243198.1200	184920.1900	228117.7300	335492.1900	307789.0600	333046.2200	356751.5300	420356.9100	420374.5900	447180.8800	306178.2200	166587.9500	395674.6600	391006.6200	249932.5000	302058.0900	334586.5900	213076.2300	292290.7500	443492.9700	263495.5300	389329.1600	319096.8800	360783.2500	262648.7800	336193.9700	260654.5000	280117.7800	281508.3800	342357.3400	329262.1600	249700.6100	386708.2500	237691.8800	844153.0000	279415.5600	280729.3400	248353.1200	254239.5600
TG(47:3)	84059.9100	37764.2200	96952.7300	72826.8200	77208.3100	83806.8500	83126.4500	84433.0200	64018.4200	81086.5900	80135.7700	72837.8900	66942.6400	84267.5900	71071.4100	66994.1300	100351.1000	53511.4300	86204.0500	80447.1200	29799.7600	87354.1600	101722.6200	78784.5300	55773.7800	49833.4000	72724.3400	61184.2700	87508.3800	97289.8400	102942.7700	85216.1700	83890.9800	89262.7800	51403.9400	95667.1300	87733.0300	78169.1800	48813.6300	67599.6600	57907.7200	75254.9700	94877.5300	78455.5300	72081.9600	78738.5100	110552.8700	54779.2000	80594.2700	39232.5300	63345.5700	61866.5100	53756.6300	64200.3000	66592.1400	61349.5400	108158.5300	50183.9200	97786.8000	76786.9300	63559.7200	41635.8400
TG(O-31:5_16:0)	22005.6100	60071.9100	22046.9700	17602.7700	41514.4600	36438.1100	45385.1600	44186.4400	25452.2300	30957.7200	31328.7900	29257.8400	23733.5900	24326.1200	31336.5200	14735.0900	38253.8800	23415.8700	36581.0700	39037.4200	27147.8300	48852.5800	21589.2900	25201.7400	41803.2100	61630.0700	23719.2600	29880.8000	21312.2600	30573.6900	55294.4300	29053.4000	33291.1500	18192.7500	22942.4700	48342.3800	19229.9200	34059.5300	32597.5800	27036.5600	26217.8300	52300.4200	27542.0100	23505.4500	30082.9400	30300.6200	31672.6300	45689.9600	43047.7300	38603.6200	42219.8300	19871.3600	25637.2100	45895.5000	32364.2500	18302.9600	30904.3100	12700.6600	21819.8100	32500.8200	28348.8000	32506.6700
TG(O-32:3_27:2)	807676.8100	1393592.3800	2544783.2500	1281230.1200	2219645.2500	980329.0000	899040.9400	1853716.0000	642563.8800	1713433.1200	536157.0600	2205517.5000	1215258.2500	1089962.0000	1030028.1900	676326.5000	1058743.5000	4456224.5000	1772416.3800	545825.6900	708913.5000	2700817.2500	732215.1900	1512924.8800	1050124.6200	1519703.6200	1755308.0000	1321893.7500	2227453.0000	1884534.3800	1029826.0000	1743281.6200	707273.0600	1255357.5000	715345.9400	714024.8100	1900281.6200	736287.2500	1408697.1200	936734.5000	1486059.3800	873432.2500	1510635.0000	2071542.6200	599575.5600	1163071.5000	3233295.2500	2642760.2500	1431724.8800	711561.4400	1830706.3800	1563062.3800	819187.6900	816896.9400	983150.0600	1317130.5000	1226997.8800	120050.6000	467062.3800	1198455.3800	255020.0200	1093853.1200
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	pubchem_id	inchi_key	kegg_id	other_id	other_id_type	ri	ri_type	moverz_quant	
AcCa(2:0)						0.270		204.123	
Cer(d16:0_16:0)						3.203		512.504	
Cer(d16:0_18:0)						3.302		540.535	
DAP(O-16:0_O-4:0)						2.838		447.347	
DG(7:0_11:0)						1.255		395.277	
DG(O-15:1_19:1)						3.342		579.535	
DG(O-16:0)						1.809		331.284	
DG(O-18:0)						1.910		359.316	
LPC(16:0)						1.380		496.340	
LPC(18:0)						1.680		524.371	
LPC(18:1)						1.461		522.355	
LPC(18:2)						1.256		520.340	
LPC(20:3)						0.989		546.355	
MG(16:0)						1.801		331.284	
MG(18:2)						1.644		355.284	
PC(32:0)						3.057		734.569	
PC(32:1)						2.947		732.554	
PC(34:2)						2.667		758.569	
PC(36:2)						2.796		786.601	
PC(36:3)						3.006		784.585	
PC(36:4)						2.952		782.569	
PC(38:4)						2.782		810.601	
PC(38:6)						2.655		806.569	
PC(P-18:0)						1.455		522.355	
SM(d36:1)						3.029		731.606	
TG(14:0_16:0_16:0)						3.648		796.739	
TG(15:0_16:0_16:0)						3.669		810.755	
TG(16:0_16:0_16:0)						3.689		824.770	
TG(47:3)						3.629		804.708	
TG(O-31:5_16:0)						3.659		769.670	
TG(O-32:3_27:2)						3.804		937.858	
METABOLITES_END
#END